FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1276-1278 May 5, 1994 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Approximately 52,300 new cases of carcinoma of the bladder were diagnosed in the United States in 1993¹. These carcinomas struck primarily older men, who often presented with hematuria or increased frequency of urination. Patients whose cancers are detected in an early, localized stage have a 90 percent chance of surviving at least five years. If the cancer is detected after distant spread of the disease, however, the five-year survival rate drops to 9 percent¹. Clearly, techniques for the early detection of carcinoma of the bladder can have a major impact on the outcome of the disease².

Cytologic . . . [Full Text of this Article]

Case Report

Methods

Results

Discussion

Source Information

From the Departments of Pathology (R.H.H., Y.S.E.) and Otolaryngology-Head and Neck Surgery (R.H.H., P.R., D.S.), Johns Hopkins Medical Institutions, Baltimore. Presented in part at the annual meeting of the U.S. and Canadian Academy of Pathology, San Francisco, March 16, 1994.

Address reprint requests to Dr. Sidransky at the Department of Otolaryngology-Head and Neck Surgery, 818 Ross Research Bldg., 720 Rutland Ave., Baltimore, MD 21205-2195.

References

Related Letters:

Hubert Humphrey's Bladder Cancer
Homer R. J., Braund W.J., Hruban R. H., van der Riet P., Sidransky D.
Extract | Full Text  
N Engl J Med 1994; 331:880-881, Sep 29, 1994. Correspondence

This article has been cited by other articles:

• Hemstreet, G. P. III, Yin, S., Ma, Z., Bonner, R. B., Bi, W., Rao, J. Y., Zang, M., Zheng, Q., Bane, B., Asal, N., Li, G., Feng, P., Hurst, R. E., Wang, W. (2001). Biomarker Risk Assessment and Bladder Cancer Detection in a Cohort Exposed to Benzidine. JNCI J Natl Cancer Inst 93: 427-436 [Abstract] [Full Text]  
• Conejo, J. R., Parra, T., Cantero, M., Jimenez, A., Granizo, V., Gabriel de Arriba, V., Carballo, F. (1998). Detection of H-ras Mutations in Urine Sediments by a Mutant-enriched PCR Technique. Clin. Chem. 44: 1570-1572 [Full Text]  
• Caldas, C. (1998). Science, medicine, and the future: Molecular assessment of cancer. BMJ 316: 1360-1363 [Full Text]  
• Annas, G. J. (1995). The Health of the President and Presidential Candidates -- The Public's Right to Know. NEJM 333: 945-949 [Full Text]  
• Homer, R. J., Braund, W.J., Hruban, R. H., van der Riet, P., Sidransky, D. (1994). Hubert Humphrey's Bladder Cancer. NEJM 331: 880-881 [Full Text]